Pre-course Session: Investigational Medicinal Products (IMP) QP Education Course

Pre-course Session: Investigational Medicinal Products (IMP) QP Education Course

Barcelona, Spain

Course No 16182


Costs

Non-EQPA/Non-ECA Members: EUR 990,--
EQPA/ECA Members: EUR 890,--
EU GMP Inspectorates: EUR 495,--

(All prices excl. VAT)

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org

Speakers

Dr Susanne Ding, Boehringer Ingelheim, Germany

Sue Mann, Sue Mann Consultancy, U.K.

Brenda Van Assche, Janssen, Belgium

Objectives

This pre-course session provides a detailed overview of the specific characteristics in IMP manufacturing a QP must know to certify IMP batches for the release for clinical trials.

Background

The manufacture of investigational medicinal products (IMPs), including labelling, packaging, testing and certification, is carried out in accordance with the applicable GMP regulations. However, this is not a routine process, since, among other things, manufacturing and packaging procedures might be different for each and every clinical trial. The Qualified Person (QP) must therefore take into account these particularities and the GMP/GCP interface.

Target Group

New colleagues becoming IMP QPs, QPs looking for continuous training and personnel of CROs and “non-commercial” IMP organisations.

Programme

General introduction

  • Different clinical phases I to IV, focus on patient safety
  • Undefined processes (manufacture, fit for purpose control strategy, etc.)
  • Why use risk assessments & how to apply – vital core
  • of a IMP quality system
  • Diversity: IMP manufacturers, start-ups, academia…
Specific legal requirements for IMPs
  • Clinical Trial Regulation EU No. 536/2014 and the “old” Annex 13 and Directives 2001/20/EC and 2003/94/C
  • The “new” ATMP regulation
GMP meets clinical trials – Differences between IMPs and commercial Products
Packaging & labeling

  • Randomization
  • Blinding / placebos
  • Comparators
  • NIMPs / AMPs
  • Where to apply validation activities
  • The Product Specification File (PSF)
  • 3rd country manufacture of IMPs: import and the QP Declaration
Registration
  • IMPD, CTA, IND etc.
  • Regulatory compliance and the two step release procedure
GMP meets GCP
  • Interaction with clinical sites
  • Distribution
  • IRT

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK